In a hepatocellular carcinoma mouse model induced by the carcinogen diethylnitrosamine, NLRP12 has been shown to hinder the progression of hepatocellular carcinoma by reducing inflammation and limiting the proliferation of hepatocytes.140. Here, NLRP12 is linked to hepatocellular carcinoma.